Skip to content

Pulmonary Effects of 100% Biodiesel Exhaust

Pulmonary Effects of 100% Biodiesel Exhaust

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02690571
Acronym
BD100Broncho
Enrollment
15
Registered
2016-02-24
Start date
2013-10-31
Completion date
2014-04-30
Last updated
2016-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation

Keywords

Air Pollution, Biodiesel exhaust, Bronchoscopy, Metabolomics

Brief summary

Air pollution is a global environmental and health concern, contributing to onset and deterioration of respiratory and cardiovascular diseases. As climate change and dependence on diminishing fossil fuel supplies have taken center stage in political and scientific debates, renewable carbon-neutral fuels like biodiesel receive increasing attention. The most common biodiesel within the European Union, rapeseed oil methyl ester (RME) is perceived to be a green fuel, as it is sustainable and of biological origin, and therefore is often predicted to be less harmful to human health. Whilst replacing petrodiesel with biodiesel may have advantageous ecological impacts, consequences to respiratory health remained largely unexplored. The purpose of the current study is to evaluate whether inhalation of 100% RME biodiesel exhaust would result in an acute airway inflammatory response in healthy human subjects, as shown previously following exposure to petrodiesel exhaust.

Interventions

OTHERBronchoscopy

The bronchoscopy procedure was performed six hours after completion of the exposure session, with sampling of endobronchial mucosal biopsies, bronchial wash and bronchoalveolar lavage performed under topical anaesthesia.

Sponsors

Umeå University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

Normal ECG Normal Lung function Normal Blood samples

Exclusion criteria

Smoking Pre-existing metabolomic, respiratory and cardiovascular disease Exposure to high levels of pollutants in occupation

Design outcomes

Primary

MeasureTime frameDescription
Cytokines in Bronchial wash (BW)6 hoursBronchial wash (BW) collected by bronchoscopy will be analyzed for cytokines (%).
Cell counts in Bronchial Wash6 hoursBronchial wash (BW) collected by bronchoscopy will be analyzed for inflammatory cell counts (cells/ml).

Secondary

MeasureTime frameDescription
Oxylipin Metabolomic profilingBaseline, 2 hours, 6 hours, 24 hoursMetabolomic testing done with mass spectrometry on blood samples, BW and BAL.
Inflammation in bronchoalveolar lavage (BAL)6 hourBAL collected by bronchoscopy will be analyzed for inflammatory markers, such as cell counts (cells/ml).
Inflammation in endomucosal biopsies6 hoursBiopsies collected by bronchoscopy will be analyzed for inflammatory markers, such as cell counts (cells/mm2).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026